🔗 Permalink

Inventor profile of:

Kyle E. Parcella

City:

Wallingford, Connecticut

Country:

United States

Published Applications:

Last publication date:

2018-08-16

Top Assignees for applications by Kyle E. Parcella

The entities that hold a legal rights for patent applications filed by inventor Parcella Kyle E.:

BRISTOL-MYERS SQUIBB COMPANY 14 Princeton, NJ United States
ViiV HealthCare UK (No. 5) Limited 2 Brentford, Middlesex, United Kingdom
ViiV Healthcare UK (No.5) Limited 1 Brentford, Middlesex, United Kingdom

Recent patent applications by Parcella Kyle E.

Kyle E. Parcella from Wallingford, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-08-16

US20180230129A1

Chemistry; metallurgy

Substituted pyridines as inhibitors of human immunodeficiency virus replication

#2 | 2018-08-16

US20180230124A1

Chemistry; metallurgy

Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

#3 | 2018-05-31

US20180147196A1

Human necessities

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

#4 | 2017-08-31

US20170247385A1

Chemistry; metallurgy

Furopyridine compounds for the treatment of hepatitis C

#5 | 2017-05-04

US20170121340A1

Chemistry; metallurgy

Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C

#6 | 2017-04-20

US20170107202A1

Chemistry; metallurgy

Compounds useful as immunomodulators

#7 | 2017-01-12

US20170008887A1

Chemistry; metallurgy

Inhibitors of human immunodeficiency virus replication

#8 | 2016-01-28

US20160024103A1

Chemistry; metallurgy

Fused furans for the treatment of hepatitis C

#9 | 2015-09-24

US20150266886A1

Chemistry; metallurgy

Cyano containing azabenzofuran compounds for the treatment of hepatitis C

#10 | 2014-09-18

US20140275154A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#11 | 2013-08-01

US20130197012A1

Human necessities

Compounds for the treatment of hepatitis C

#12 | 2012-12-13

US20120316126A1

Human necessities

Compounds for the Treatment of Hepatitis C

#13 | 2012-09-13

US20120232099A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#14 | 2012-08-09

US20120201783A1

Human necessities

Compounds for the treatment of hepatitis C

#15 | 2011-10-20

US20110256099A1

Human necessities

Compounds for the treatment of hepatitis C

#16 | 2010-09-30

US20100249094A1

Human necessities

Compounds for the treatment of hepatitis C

#17 | 2010-07-22

US20100184800A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#18 | 2010-04-15

US20100093694A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

#19 | 2010-03-11

US20100063068A1

Chemistry; metallurgy

Compounds for the treatment of hepatitis C

InventorID:

367022 ⎘